UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden

hours per response:

0.5

1. Name and Address of Reporting Person*LANKLER DOUGLAS M

(Last)

(First)

(Middle)

PFIZER INC. ATT: CORPORATE SECRETARY

235 EAST 42ND STREET

(Street)

NEW YORK

NY

10017

(City)

(State)

(Zip)

2. Date of Event Requiring Statement

(Month/Day/Year)

04/01/2010

3. Issuer Name and Ticker or Trading Symbol

PFIZER INC

[ PFE ]

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

Director

10% Owner

Officer (give title below)

Other (specify below)

Senior Vice President

5. If Amendment, Date of Original Filed

(Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr.

4)

2.

Amount of Securities Beneficially Owned (Instr.

4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

4. Nature of Indirect Beneficial Ownership (Instr.

5)

Common Stock

80,703

Common Stock

900

By Rule 16b-3 Plan

Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr.

4)

2. Date Exercisable and Expiration Date

(Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr.

4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

6. Nature of Indirect Beneficial Ownership (Instr.

5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option (right to buy)

02/22/2010

02/21/2017

Common Stock

25,400

$25.87

Employee Stock Option (right to buy)

02/24/2008

02/23/2015

Common Stock

13,800

$26.2

Employee Stock Option (right to buy)

02/23/2009

02/22/2016

Common Stock

21,700

$26.2

Employee Stock Option (right to buy)

02/27/2006

02/26/2013

Common Stock

15,000

$29.33

Employee Stock Option (right to buy)

02/26/2007

02/25/2014

Common Stock

35,000

$37.15

Employee Stock Option (right to buy)

02/28/2005

02/27/2012

Common Stock

9,700

$41.3

Employee Stock Option (right to buy)

(1)

02/21/2011

Common Stock

9,000

$45.34

Phantom Stock Units SSP

(2)

(2)

Common Stock

4,063

(3)

Stock Appreciation Rights

02/26/2014(4)

02/26/2014(4)

Common Stock

23,818

$12.7

Stock Appreciation Rights

02/25/2015(4)

02/25/2015(4)

Common Stock

32,855

$17.69

Stock Appreciation Rights

12/31/2014(4)

12/31/2014(4)

Common Stock

21,413

$18.19

Stock Appreciation Rights

02/28/2013(4)

02/28/2013(4)

Common Stock

12,200

$22.55

Explanation of Responses:

1. The options became exercisable in three annual installments beginning on February 22, 2002.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

3. Each unit represents one phantom share of common stock.

4. The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

Remarks:

poadl10.HTM

Lawrence A. Fox, by power of atty., for Douglas M. Lankler

04/07/2010

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,

see

Instruction

(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations

See

18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,

see

Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.